Press Release April 2017:
MN-SBIR companies selected for Regenerative Medicine Grants
Minneapolis, MN — Three Minnesota companies working with MN-SBIR were selected as recipients of grant funding from Regenerative Medicine Minnesota (RMM). Peyant Solutions, B-MoGen Biotechnologies, and MNPHARM were all selected among the group’s 2017 Biobusiness award winners.
MN-SBIR helps companies access non-dilutive federal research and development funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs as well as the RMM. MN-SBIR provides companies with education, training, resources, and consulting services to assist companies in applying for the federal funding.
MNPHARM is a Semi-Finalist in the 2015 MN Cup competition
KSTP Channel 5 – May 6, 2015
KARE Channel 11 – May 13, 2015
St Paul, Mn. … Pioneer Press
Duluth, Mn. … Duluth News Tribune
Lino Lakes, Mn. … Quad Press
Ramsey County Review
Must Watch Videos: